The ever-expanding myokinome: discovery challenges and therapeutic implications
Crossref DOI link: https://doi.org/10.1038/nrd.2016.153
Published Online: 2016-09-12
Published Print: 2016-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Whitham, Martin
Febbraio, Mark A.
Text and Data Mining valid from 2016-09-12
Article History
First Online: 12 September 2016
Competing interests
: M.A.F is a holder of patents for IC7, a gp130 receptor ligand.